Kala Bio (KALA) Work In Process (2018 - 2019)

Kala Bio (KALA) posted Work In Process of $6.9 million for Q2 2019, up 62.94% sequentially from $4.3 million in Q1 2019.

Kala Bio (KALA) Work In Process (2018 - 2019) Analysis & Trends

Kala Bio has reported Work In Process for 2 years, with the latest figure at $6.9 million in Q2 2019.

Quarterly Work In Process changed N/A year-over-year to $6.9 million in Q2 2019, while the trailing twelve-month figure through Jun 2019 was $6.9 million (changed N/A YoY) and the FY2018 annual result came in at $3.4 million, changed N/A from the prior year.
Work In Process improved to $6.9 million in Q2 2019 per KALA's latest filing, from $4.3 million in the prior quarter.
Over five years, Work In Process peaked at $6.9 million in Q2 2019 and troughed at $976000.0 in Q3 2018.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Vertex Pharmaceuticals	138.90 Bn	131.05 Bn	2.84 Bn
2	Regeneron Pharmaceuticals	86.10 Bn	78.11 Bn	3.93 Bn
3	Argenx Se	65.56 Bn	60.37 Bn	1.37 Bn
4	Moderna	55.82 Bn	50.68 Bn	52.00 Mn
5	BeOne Medicines	42.14 Bn	37.04 Bn	1.53 Bn
6	Alnylam Pharmaceuticals	31.67 Bn	28.36 Bn	992.69 Mn
7	BioNTech SE	27.74 Bn	9.35 Bn	668.28 Mn
8	Insmed	27.53 Bn	26.37 Bn	358.27 Mn
9	Royalty Pharma	27.38 Bn	26.54 Bn	-
10	Kala Bio	9.97 Mn	9.97 Mn	-

Download Data